May 4, 2016 — Acutus Medical announced CE Mark approval for its AcQMap High Resolution Imaging and Mapping System and AcQMap Catheter, enabling the company to initiate commercial activities.
According to the company, the system is the first and only to detect and display both standard voltage-based and higher resolution charge-source (dipole density) maps. The system is also able to generate real-time, 3-D images of the heart chamber using ultrasound with quality comparable to a computed tomography (CT) or magnetic resonance imaging (MRI) in a matter of minutes. Dipole, non-contact mapping creates a highly accurate, instantaneous global view that captures the activation pattern of every heartbeat making it uniquely capable of mapping and displaying both stable and unstable cardiac arrhythmias.
“During a recent AcQMap procedure, we were able to systematically map atrial fibrillation (AF) and eliminate the identified sites of interest, ultimately restoring the patient to their native rhythm,” said Andrew Grace, M.D., Ph.D., from Cambridgeshire, U.K.-based Papworth Hospital. “The ability to map and quickly re-map after each set of ablations makes it possible to truly visualize AF and to achieve sinus rhythm.”
The AcQMap High Resolution Imaging and Mapping System is not available for sale in the United States.
For more information: www.acutusmedical.com
July 31, 2024 
